Ursodeoxycholic acid and/or antibiotics for prevention of biliary stent occlusion

Cochrane Database of Systematic Reviews

Volumn 2010, Issue 1, 2002, Pages

  Galandi, Daniel ^a   Schwarzer, Guido ^b   Bassler, Dirk ^c   Allgaier, Hans Peter ^a  

^a University Medical Center ^*  (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CHOLAGOGUE; URSODEOXYCHOLIC ACID;

CHOLESTASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; EQUIPMENT; HUMAN; RANDOMIZED CONTROLLED TRIAL; REVIEW; STENT;

ANTI-BACTERIAL AGENTS; CHOLAGOGUES AND CHOLERETICS; CHOLESTASIS; DRUG THERAPY, COMBINATION; EQUIPMENT FAILURE; HUMANS; RANDOMIZED CONTROLLED TRIALS; STENTS; URSODEOXYCHOLIC ACID;

EID: 0036046719     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003043     Document Type: Review

References (28)

1. Barrioz T, Ingrand P, Besson I, de Ledinghen V, Silvain C, Beauchant M. Randomised trial of prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin. Lancet 1994;344(8922):581-2.
2. De Ledinghen V, Person B, Legoux JL, Le Sidaner A, Desaint B, Greff M, et al. Prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin. A multicenter randomized trial. Digestive Diseases and Sciences 2000;45(1):145-150.
3. Ghosh S, Palmer KR. Prevention of biliary stent occlusion using cyclical antibiotics and ursodeoxycholic acid. Gut 1994;35(12):1757-9.
4. Luman W, Ghosh S, Palmer KR. A combination of ciprofloxacin and rowachol does not prevent biliary stent occlusion. Gastrointestinal Endoscopy 1999;49(3):316-21.
5. Sung JJY, Sollano JD, Wai Lai C, Ismael A, Yung MY, Tumala I, et al. Long-term ciprofloxacin treatment for the prevention of biliary stent blockage: a prospective randomized study. American Journal of Gastroenterology 1999;94(11):3197-3201.
6. Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992;340(8834-8835):1488-92.
7. Smit JM, Out MM, Groen AK, Huibregtse K, Jansen PL, van Marle J, et al. A placebo-controlled study on the efficacy of aspirin and doxycycline in preventing clogging of biliary endoprostheses. Gastrointestinal Endoscopy 1989;35(6):485-9.
8. Andersen JR, Sørensen SM, Kruse A, Rokkjaer M, Matzen P. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut 1989;30(8):1132-5.
9. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50(4):1088-101.
10. Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992;340(8834-8835):1488-92.
11. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7(3):177-88.
12. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. British Medical Journal 1994;309:1286-1291.
13. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(9):629-34.
14. Galandi D, Bassler D, Schwarzer G, Allgaier HP. Ursodeoxycholic acid and/or antibiotics for prevention of biliary stent occlusion (Protocol for a Cochrane Review). The Cochrane Library 2001, Issue 2.
15. Groen AK, Out T, Huibregtse K, Delzenne B, Hoek FJ, Tytgat GN. Characterization of the content of occluded biliary endoprostheses. Endoscopy 1987;19(2):57-9.
16. Hagenmuller F, Soehendra N. Non-surgical biliary drainage. Clinics in Gastroenterology 1983;12(1):297-316.
17. Huibregtse K, Katon RM, Coene PP, Tytgat GN. Endoscopic palliative treatment in pancreatic cancer. Gastrointestinal Endoscopy 1986;32(5):334-8.
18. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
19. Leung JW, Ling TK, Kung JL, Vallance-Owen J. The role of bacteria in the blockage of biliary stents. Gastrointestinal Endoscopy 1988;34(1):19-22.
20. Libby ED, Leung JW. Prevention of biliary stent clogging: a clinical review. American Journal of Gastroenterology 1996;91(7):1301-8.
21. Moesch C, Sautereau D, Cessot F, Berry P, Mounier M, Gainant A, et al. Physicochemical and bacteriological analysis of the contents of occluded biliary endoprostheses. Hepatology 1991;14(6):1142-6.
22. Nagakawa T, Konishi I, Higashino, Y, Ueno K, Ohta T, Kayahara M, et al. The spread and prognosis of carcinoma in the region of the pancreatic head. Japanese Journal of Surgery 1989;19(5):510-8.
23. Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta-analysis of the published literature for survival endpoints. Statistics in Medicine 1998;17:2815-2834.
24. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12.
25. Siegel JH, Snady H. The significance of endoscopically placed prostheses in the management of biliary obstruction due to carcinoma of the pancreas: results of nonoperative decompression in 277 patients. American Journal of Gastroenterology 1986;81(8):634-41.
26. Smith AC, Dowsett JF, Russell RC, Hatfield AR, Cotton PB. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 1994;344(8938):1655-60.
27. Speer AG, Cotton PB, Rode J, Seddon AM, Neal CR, Holton J, et al. Biliary stent blockage with bacterial biofilm. A light and electron microscopy study. Annals of Internal Medicine 1988;108(4):546-53.
28. Sterne JAC, Gavaghan DJ, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. Journal of Clinical Epidemiology 2000;53:1119-1129.